Connect with us

Technology

Redox Launches AI Capabilities Built to Scale Integration Teams and Serve as the Data Foundation for AI in Healthcare

Published

on

New MCP server, AI Assistant Suite, and intelligent in-flight data processing features help organizations scale: smarter integration workflows for their teams, and a trusted data infrastructure layer for their AI investments

MADISON, Wis., June 23, 2026 /PRNewswire/ — Redox, the leading healthcare data interoperability partner, today announced the launch of several artificial intelligence (AI) capabilities integrated across Redox Engine, the company’s interoperability platform. The launch empowers healthtech, health system, health plan, EHR, and med tech organizations in two distinct ways. First, new capabilities were added into the platform itself. An MCP (Model Context Protocol) server and an AI Assistant Suite join the AI powered composable workflow building blocks released last fall, enabling teams to automate and scale their integration workflows. All AI features are built with a governance-by-design approach that ensures AI operates within the security and compliance boundaries healthcare demands. Second, Redox strengthens its role as the healthcare data infrastructure layer, delivering the complete, clean, and normalized data that customers’ AI applications need to perform reliably in production. Together, these capabilities position Redox as both a smarter platform for integration teams and a trusted foundation for the AI-powered healthcare ecosystem; reducing total cost of ownership while raising the bar on what integration infrastructure can do. Since general availability launched three weeks ago, nearly 70 users have adopted the features.

Redox powers intelligent healthcare data exchange across a connected network of more than 12,000 organizations. For over a decade, that network has enabled customers to connect once and exchange data across the healthcare ecosystem—including EHRs, cloud platforms, labs, HIEs, national networks like TEFCA, and more. As data sources, standards, and technology demands have multiplied, the challenge has shifted: it’s no longer enough to just get data connected. Teams need to control how the data moves, ensure it’s ready to use when it arrives, and adapt quickly when something changes. In other words, the data needs to be usable, not just available. When teams are feeding data to AI tools, this shift further compounds. Redox’s AI capabilities are designed to meet these challenges.

“A beta customer told us that in 15 minutes, Redox’s MCP server did what used to take two full days. That’s not a product metric — that’s a signal that we built something that actually changes how the work gets done,” said Rachel Witalec, Chief Product Officer at Redox. “Integration teams have been carrying an enormous, often invisible, burden for too long. These AI capabilities are for them. Our goal is to free teams to focus on more strategic initiatives, whether that’s standing up their first integration or scaling to their hundredth.”

AI Integrated Across Redox Engine
Redox Engine, Redox’s AI-enabled healthcare data interop platform, together with their connection network and deep interop expertise, creates a modern data infrastructure layer that empowers teams and the AI tools they rely on.

Built around the simple premise that teams need different interfaces to the same powerful infrastructure, the new capabilities offer complementary paths: a headless, API-first experience via the Redox MCP server and an AI-assisted dashboard experience. Intelligent orchestration building blocks can be leveraged via both paths. 

1. Headless Access

The Redox MCP server enables customers to manage their Redox Engine environment via natural language and any MCP-compatible AI client customers already use — Claude, Cursor, Copilot, and more. The MCP server goes beyond answering questions; it autonomously executes actions across the integration lifecycle, from setup to environment promotion. It can perform multiple actions simultaneously.

Redox’s “bring your own AI model” approach avoids additional security approvals and procurement bottlenecks by using tools already vetted and approved by customer organizations.

2. AI-Assisted Dashboard Experience

Redox has introduced the AI Assistant Suite, purpose-built to simplify integration development, accelerate troubleshooting, and empower teams across every level of technical expertise. Users can trigger these assistants with a single click or a natural language prompt to receive straightforward, plain-language summaries. The AI Assistants improve efficiency for technical staff while equipping less technical users to oversee integrations independently. At launch, this suite features:

Config Modifier AssistantLog Summary AssistantPayload Summary Assistant

These optional tools prompt teams to review and validate AI-generated output before acting on it, ensuring they maintain control at every step.

3. Intelligent Orchestration

Organizations can also leverage AI tools directly inside data workflows, enabling teams to perform high-value tasks in-flight and deliver clean, AI-ready data downstream.  By combining modular building blocks, customers are able to launch custom, high-impact workflows in as little as four weeks.

For example, one large health system is routing PDFs through an AWS LLM to automatically classify and route incoming faxes, eliminating manual triage and improving throughput velocity. Another customer is routing data to their in-house LLM to generate instant clinical summaries that are then sent back to the EHR. High impact, useful data workflows like these no longer require expensive consultants or weeks of engineering time. Redox Engine’s intelligent orchestration building blocks can be incorporated into workflows, and swapped in or out, at any time.

“Anyone can build a prototype now. What you can’t replicate is 14 years of production experience with the ways healthcare data actually behaves at the last mile; the edge cases, the EHR-specific quirks, the configurations that only exist because someone hit that exact failure in the real world,” said Sasi Mukkamala, Chief Technology Officer at Redox. “That’s the foundation our AI capabilities are built on, and it’s why they hold up where others don’t.”

Governance by Design, Not as an Afterthought
All AI capabilities are designed to support HIPAA compliance and enterprise governance requirements. They inherit Redox’s enterprise-grade security and compliance controls. PHI is never used to train AI models—any data that could contain PHI is stored in a restricted, auditable environment and permanently deleted within 60 days. Where training data is used, it is anonymized and aggregated.

Role-based access controls (RBAC) govern every AI feature, so AI capabilities can only access the data the logged-in user is authorized to see, with no elevated access or side channels. AI assistants are invocation-based—they only activate when a user explicitly triggers them, with no passive AI processing. Redox is aligned to HITRUST AI security controls and is building to that standard today.

Availability
The AI Assistant Suite, MCP server, and intelligent orchestration building blocks are all available for use by customers today.

To learn more or connect with the Redox team, visit www.redoxengine.com.

About Redox
Redox is your healthcare data interoperability partner. We help provider, payer, healthtech, EHR, and medtech organizations power better care with seamless data interoperability. Our secure platform’s read/write capabilities translate, normalize, enrich, and orchestrate complex healthcare data in real time. With a connected network of more than 12,000 organizations, customers use Redox Engine to accelerate connected healthcare across a wide range of systems, applications, and workflows. For more information, visit www.redoxengine.com or follow us on LinkedIn.

Media Contact: press@redoxengine.com

View original content:https://www.prnewswire.com/news-releases/redox-launches-ai-capabilities-built-to-scale-integration-teams-and-serve-as-the-data-foundation-for-ai-in-healthcare-302807041.html

SOURCE Redox Inc.

Continue Reading

Technology

Stowers Institute partners with Google DeepMind and leading research institutions to help reveal the regulatory language of the human genome

Published

on

By

Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time, scientists can explore a comprehensive map of more than 9 billion possible single-letter DNA changes through a web browser, helping them more quickly prioritize and interpret variants that may influence biology and disease and lay groundwork for future treatments. 

KEY HIGHLIGHTS 

Developed over several years, AlphaGenome Atlas is a one-petabyte dataset containing molecular-effect predictions for more than 9 billion possible single-letter DNA changes across the human genome.Until now, researchers lacked a single resource that could both rank variants across the genome and reveal the biological processes they are predicted to disrupt, a combination that could accelerate foundational discoveries, disease research and the search for therapeutic targets.Researchers from Google DeepMind, the Stowers Institute for Medical Research, Broad Institute, the University of Exeter, Memorial Sloan Kettering Cancer Center and Stanford University contributed scientific input and explored applications of the resource.

KANSAS CITY, Mo., Sept. 8, 2026 /PRNewswire/ — The human genome contains approximately 3 billion DNA letters, creating more than 9 billion possible single-letter changes. Testing the effects of each change in a laboratory would be practically impossible. Google DeepMind’s new AlphaGenome Atlas, available beginning today, gives scientists a comprehensive, searchable resource designed to accelerate understanding of the human genome.

The one-petabyte resource contains artificial intelligence-generated predictions for the molecular effects of more than 9 billion possible changes, creating what Google DeepMind describes as the most comprehensive catalogue of its kind.

Stowers Institute for Medical Research Investigator Julia Zeitlinger, Ph.D., partnered with the Google DeepMind team led by Vice President of Science and Chief Scientist Žiga Avsec, Ph.D., to map and interpret the patterns in DNA that regulate biological processes inside cells. At the same time, additional scientific collaborators from leading institutions across the United States and England helped test how the new resource could be used to identify impactful genetic variation in humans. The work is now available as a preprint on bioRxV. 

Zeitlinger has made significant contributions to the field of gene regulation and computational biology. In 2019, in an international collaboration that included Avsec, Zeitlinger and her team at the Stowers Institute developed a powerful AI framework, BPNet. This framework is now widely used to extract and dissect the DNA sequences that explain genome-wide biological data. Just last month, her lab unveiled a new AI method, PISA, which generates high-resolution visualizations of what AI models have learned from DNA. 

Stowers Institute Bioinformatics Scientist and Zeitlinger Lab member, Melanie Weilert, served as a lead author on the AlphaGenome project. With her deep expertise in interpretating AI models, she helped build the AlphaGenome Atlas resource to ask one of biology’s biggest questions: How does a cell know which genes to turn on and off?

“This is a very difficult problem because every cell type speaks a slightly different language, making it hard to know which rules are general,” Zeitlinger said. “With AlphaGenome, we can quickly query many cell types and look for general patterns by which genes are activated and repressed.”

Google DeepMind developed the technology behind the Atlas. Zeitlinger, who also leads the Stowers Institute’s AI Initiative, helped connect its predictions to the biological processes that give cells their identities and allow them to function.

“AlphaGenome Atlas is a powerful example of how AI can expand human knowledge and advance scientific discovery,” said VP Science, Google DeepMind and Chief Scientist, Google Cloud, Pushmeet Kohli, Ph.D. “By making this resource widely available, we hope scientists around the world can use it to better understand the language of life and what happens when individual letters in the human genome change.”

Scientists can access the resource through a web browser without writing code, allowing more researchers to explore genetic variation at a scale that was not previously possible.

“AlphaGenome Atlas is foundational research with the potential to have an impact across multiple areas of biology,” said Avsec. “We worked with experts in the field, including Julia, whose biological insight helped us explore how the resource can map functional elements in the genome and reveal their roles at the molecular level.” 

How Stowers scientists helped reveal the regulatory “words” of the genome

Every cell in the human body contains essentially the same DNA, yet different cells use that information in very different ways. Short DNA sequences called motifs act as regulatory instructions, helping control which genes are active, when they are activated and how strongly they operate.

Zeitlinger and her team used AlphaGenome Atlas to analyze regulatory motifs across the genome and determine what they reveal about the proteins, called transcription factors, that control gene activity. The researchers categorized these regulatory signals by function, distinguishing transcription factors that change whether DNA is accessible from those that also activate or repress genes.

Conducting this type of analysis experimentally across thousands of sites and many different cell types would require enormous time and resources. By making genome-wide predictions available in one searchable resource, the Atlas allowed Zeitlinger’s team to identify broader patterns in how genes are regulated and begin defining the general rules underlying the regulatory language of DNA.

“Having these motifs mapped at base-pair resolution across the genome and in many cell types gives us a searchable dictionary for non-coding DNA,” Zeitlinger said. “By giving the scientific community access to these predictions, AlphaGenome Atlas can accelerate how we identify potentially disease-causing variants while helping us understand the fundamental rules by which genes are regulated.”

“This collaboration demonstrates how Stowers scientists are helping shape emerging technologies, not simply adopting them,” said Stowers Institute President and Chief Scientific Officer Alejandro Sánchez Alvarado, Ph.D. “By pairing deep biological knowledge with the capabilities of AI, researchers can ask questions at a scale that was not previously possible and create new opportunities to more clearly understand human health and disease.”

The Atlas does not replace laboratory research. Instead, it can help scientists determine which variants and biological mechanisms should be investigated first, focusing experimental time and resources on the most promising questions.

“Tools such as AlphaGenome Atlas become most valuable when their predictions can be connected to meaningful biological questions,” said Stowers Institute Scientific Director Kausik Si, Ph.D. “Julia’s work brings together deep expertise in gene regulation and computational biology to help move us from simply reading DNA sequence toward understanding the rules that control gene activity.”

From billions of variants to focused biological questions 

AlphaGenome Atlas contains thousands of molecular-effect predictions for each variant across hundreds of human cell types and tissues. These predictions contribute to the new AlphaGenome Variant Impact, or AVI, score. They also enabled researchers to identify and map recurring DNA motifs, short sequences where transcription factors bind to help control gene activity.

The AVI score brings together predictions from AlphaGenome, AlphaMissense and evolutionary conservation data. It gives researchers a single measure for ranking variants by their potential impact across protein-coding and non-coding regions of the genome. Researchers can then examine which molecular processes, including gene expression, RNA splicing and protein function, are predicted to be affected.

The collaborating institutions explored how the resource could support several areas of human genetic research. Scientists at the Broad Institute used the AVI score to prioritize a previously overlooked non-coding variant associated with an unsolved rare disease case. At the University of Exeter, researchers applied Atlas to genomic data from more than 54,000 UK Biobank participants, uncovering additional associations between rare noncoding variants and protein levels. 

Watch a video from Google DeepMind and read a blog post announcing AlphaGenome Atlas.

Learn more and watch a tutorial of AlphaGenome Atlas 

AlphaGenome Atlas is available for non-commercial use through Google DeepMind’s website at deepmind.google.com/science/alphagenome/atlas. Its predictions are intended to support research and have not been validated or approved for clinical use.

About the Stowers Institute for Medical Research 

Founded in 1994 through the generosity of Jim Stowers, founder of American Century Investments, and his wife, Virginia, the Stowers Institute for Medical Research is a nonprofit, biomedical research organization with a focus on foundational research. Its mission is to expand our understanding of the secrets of life and improve life’s quality through innovative approaches to the causes, treatment, and prevention of diseases.

The Institute consists of 24 independent research programs. Of the approximately 500 members, over 370 are scientific staff that include principal investigators, fellows, technology center directors, postdoctoral scientists, graduate students, and technical support staff. Learn more about the Institute at stowers.org and about its graduate program at stowers.org/gradschool. 

Read an online version of the release here. 

Media contact 

Joe Chiodo 
Director of Communications 
Stowers Institute for Medical Research 
724-462-8529 
chiodo.joe@stowers.org 

View original content to download multimedia:https://www.prnewswire.com/news-releases/stowers-institute-partners-with-google-deepmind-and-leading-research-institutions-to-help-reveal-the-regulatory-language-of-the-human-genome-302872938.html

SOURCE Stowers Institute for Medical Research

Continue Reading

Technology

The Inner Circle acknowledges Daniel Beer as a Pinnacle Professional Member Inner Circle of Excellence

Published

on

By

NEW YORK, Sept. 8, 2026 /PRNewswire/ — Prominently featured in The Inner Circle, Daniel Beer is acknowledged as a Pinnacle Professional Member Inner Circle of Excellence for his contributions to Information Technology and Artificial Intelligence.

Daniel Beer has built a distinguished career as a technology executive, entrepreneur, and innovator dedicated to helping organizations harness technology to achieve sustainable growth and meaningful collaboration. As founder and chief executive officer of Trusted Associates and chief executive officer of Freeman and Clarke Inc., he leads initiatives that combine strategic technology leadership with emerging innovations in artificial intelligence and digital transformation.

Mr. Beer specializes in information technology strategy, platform development, organizational modernization, digital infrastructure, and fractional chief information officer and chief technology officer services. Through Freeman and Clarke Inc., he provides executive technology leadership that enables organizations to align technology investments with long term business objectives. At Trusted Associates, he focuses on developing collaborative technology platforms, cultivating strategic partnerships, creating innovative applications, and making investments in artificial intelligence companies that advance practical, real world solutions.

Mr. Beer earned a Bachelor of Music Education from the University of Sydney in 1997 before completing an equivalency certification for a Bachelor of Applied Science in Computer Science through the University of Maryland in 2012. His unique educational background combines creativity with technical expertise, allowing him to approach technology challenges with both analytical precision and innovative thinking.

Throughout his career, Mr. Beer has consistently demonstrated visionary leadership. He founded Techknowledgy Group at the age of 20 and successfully grew the company into a respected managed services provider over a fifteen year period. Later, as Chief Information Officer for the New York Hotel Trades Council, he led the modernization of the organization’s information systems and digital infrastructure, significantly improving operational efficiency and technology capabilities. Today, he continues expanding his influence through leadership roles with Trusted Associates, Freeman and Clarke Inc., and as an investor and advisory board member for Relate Research and Technology Company.

His professional accomplishments have earned recognition through inclusion in Marquis Who’s Who Top Executives, honoring his leadership, innovation, and contributions to the field of information technology.

Outside of his professional endeavors, Mr. Beer enjoys singing in church choirs, supporting personal development programs, and participating in animal rescue efforts, including fostering and rescuing dogs alongside his family. He credits the mentors who invested in his growth without expecting anything in return for shaping both his leadership philosophy and his commitment to serving others.

Looking ahead, Mr. Beer plans to continue advancing technology solutions that promote global collaboration while pursuing initiatives that improve literacy, raise awareness of neurodiversity, reduce incarceration rates, and create opportunities that benefit society as a whole. He remains committed to using innovation as a force for positive change.

Guided by his W5 philosophy, Mr. Beer believes true success is measured by helping others succeed. Through collaboration, communication, service, and innovation, he continues to build organizations and technologies that create lasting value for clients, communities, and future generations.

Contact: Katherine Green, 516-825-5634, editorialteam@continentalwhoswho.com

View original content:https://www.prnewswire.com/news-releases/the-inner-circle-acknowledges-daniel-beer-as-a-pinnacle-professional-member-inner-circle-of-excellence-302872896.html

SOURCE The Inner Circle

Continue Reading

Technology

Thoma Bravo Announces Strategic Growth Investment in Tanda

Published

on

By

Investment to accelerate Tanda’s product innovation and global growth

BRISBANE, Australia and SAN FRANCISCO, Sept. 8, 2026 /PRNewswire/ — Thoma Bravo, the world’s largest software-focused investment firm, today announced a strategic growth investment in Tanda, a leading workforce management, payroll and HR platform for shift-based workers. Thoma Bravo’s investment will support Tanda’s continued product innovation, including the company’s AI roadmap and its expansion into new markets. Tanda’s co-founders will remain significant shareholders and will continue to lead the company, with Jake Phillpot remaining Chief Executive Officer. Terms of the transaction were not disclosed.

Tanda is the market leader in workforce management for shift-based employers, serving approximately 8,000 businesses globally across hospitality, retail, quick-service restaurants, healthcare and other frontline industries. Tanda’s integrated workforce management platform combines employee recruiting, onboarding, rostering, time and attendance, gross wage calculations and payroll on a single codebase. This natively built product suite enables employers in complex, highly regulated markets to manage compliance and ensure employees are paid accurately. Trusted by thousands of organizations, Tanda’s platform powers the daily operations of some of the most demanding frontline businesses in the world.

“Taking on an investor was a very big decision for Tanda,” said Jake Phillpot, Co-Founder & Chief Executive Officer of Tanda. “We’ve been a bootstrapped company with no outside capital since we were founded 14 years ago. What started as an idea when we were still housemates at university has become a global business that we have built without taking shortcuts. Through a lot of hard work, we have market-leading products, growing market share and so much more room to grow. We thought the time was right to take on our first investor.”

“Thoma Bravo was the obvious choice as our financial partner,” Phillpot continued. “They understand software at an extraordinary level, have spent decades helping companies like ours scale and share our ambition for what Tanda can become. By partnering with the world’s number one software investor, we intend to become the global category leader in our space. Most importantly, the things that make Tanda precious won’t change. The founders will still come to work every day, and we’ll still obsess over how we can make our products better for our customers.”

“Managing and compensating employees accurately is a fundamental obligation of all employers, yet it remains a universal challenge, particularly for businesses with shift-based employees,” said Carl Press, a Partner at Thoma Bravo. “Employers are frustrated by a patchwork of legacy systems that cannot address their complex needs and expose them to operational and legal risks. Jake and his co-founders identified this problem and built Tanda from the ground up with customers and their employees at the center of every product decision. In doing so, they’ve laid the groundwork to become the definitive AI-native workforce management solution in the shift-based economy. We couldn’t be more thrilled to help them drive the next chapter of accelerated growth and innovation.”

“Tanda has everything we look for in an investment: market leadership, a fiercely loyal customer base and a product-first founding team with deep domain expertise,” said Adam Kinalski, a Principal at Thoma Bravo. “Jake and his co-founders have built a rare business that matches strong product-market fit with exceptional operational execution. We’re excited to partner with them on their mission to make Tanda the global standard in workforce management and payroll software for shift-based employers.”

Barrenjoey Advisory Pty Ltd is serving as financial advisor to Tanda, and SBA Law is serving as legal counsel. Piper Sandler & Co. is serving as exclusive financial advisor to Thoma Bravo, and Kirkland & Ellis LLP and Allens are serving as legal counsel.

About Thoma Bravo
Thoma Bravo is the world’s largest software-focused investment firm, with approximately $170 billion in assets under management as of June 30, 2026. Partnering with some of the world’s most sophisticated investors, Thoma Bravo’s private equity and private credit platforms reflect a focused investment strategy, supported by disciplined execution, deep sector expertise and leadership continuity. Over the past 20-plus years, Thoma Bravo has acquired or invested in approximately 600 software and technology companies, representing more than $325 billion of aggregate enterprise value (including control and non-control investments, as well as add-on acquisitions). Learn more at thomabravo.com and on LinkedIn.

About Tanda
Founded in 2012 and headquartered in Brisbane, Australia, Tanda (operating internationally as Workforce.com) is an all-in-one payroll, HR and workforce management system for businesses with shift-based and hourly workforces. Tanda’s platform brings rostering, time and attendance, award interpretation, compliance, payroll and HR onboarding together in a single system, helping employers in hospitality, retail, healthcare and other frontline industries schedule efficiently and pay employees accurately. The company serves thousands of customers across Australia, North America, the United Kingdom and Southeast Asia. For more information, visit tanda.co.

For Thoma Bravo

Abby Farr
Vice President, Communications & Marketing
+1 646-957-2067
afarr@thomabravo.com    

For Tanda

Georgie Pollok
Head of Marketing
media@tanda.com.au 

View original content to download multimedia:https://www.prnewswire.com/news-releases/thoma-bravo-announces-strategic-growth-investment-in-tanda-302872908.html

SOURCE Thoma Bravo

Continue Reading

Trending